January 25, 2023 Researchers at the Gillings School found that bivalent boosters are more effective than original monovalent boosters at preventing COVID-19-related hospitalization and death, according to a new study in The New England Journal of Medicine.
October 20, 2022 The National Cancer Institute has awarded UNC researchers $10.9 million in funding to further enhance treatment solutions for pancreatic cancer by focusing on key challenges to identifying, producing and directing new therapies.
September 27, 2022 A new JAMA study of more than 10 million North Carolinians highlights just how effective COVID-19 vaccines, boosters and prior infection can be, both in reducing the risk of future infection and in preventing hospitalization and death.
September 26, 2022 Lin leads new research into COVID-19 vaccine protections, Planey receives funding to study expansion of health systems, West talks climate change with the Weather Channel and Browne receives leadership award.
September 15, 2022 During the Fall 2020 semester, UNC explored hybrid options to minimize COVID-19 transmission while still offering an on-campus experience for students. New research from the Gillings School sheds light on how this experience impacted COVID-19 cases among undergraduates.
August 18, 2022 "Our message is that people should take as many steps as possible throughout the day at any walk pace, trying to work in a brisk walk for part of the day to gain the greatest benefit in lowering their risk of diabetes."
August 15, 2022 Hincapie-Castillo assesses COVID-19 dashboards in public schools, Rothenberg is named RTI International's Mentee of the Year and students from biostatistics are honored for research.
August 12, 2022 Gillings faculty have recently completed four GILs, including two from Round 6 of GIL funding and two from the special COVID-19 round of funding. The results of their work have furthered our understanding of energy storage, brain health, environmental exposures, viral transmission, pandemic response and more.
July 15, 2022 A clinical trial led by the NIH, with support from the Duke Clinical Research Institute and the Gillings School, recently showed that using infliximab or abatacept to treat adults hospitalized with COVID-19 did not shorten recovery time but did improve survival rates.
May 27, 2022 Researchers have uncovered 45 common genetic variations that could help health care providers better understand the genetic factors that impact behavioral and mental health and identify those who may be at higher risk for neurological disorders.
